Table of contents of journal:

Results: 26-41/41

Ribozymes - Their design and use in cancer

Authors: Turner, PC

Citation: Pc. Turner, Ribozymes - Their design and use in cancer, ADV EXP MED, 465, 2000, pp. 303-318

The approach of triple helix formation in control of gene expression and the treatment of tumors expressing IGF-I

Authors: Upegui-Gonzalez, LC Francois, JC Ly, A Trojan, J

Citation: Lc. Upegui-gonzalez et al., The approach of triple helix formation in control of gene expression and the treatment of tumors expressing IGF-I, ADV EXP MED, 465, 2000, pp. 319-332

Dendritic cell-based immunization for cancer therapy

Authors: Morse, MA Lyerly, HK

Citation: Ma. Morse et Hk. Lyerly, Dendritic cell-based immunization for cancer therapy, ADV EXP MED, 465, 2000, pp. 335-346

Hybrid cell vaccination for cancer immunotherapy

Authors: Walden, P

Citation: P. Walden, Hybrid cell vaccination for cancer immunotherapy, ADV EXP MED, 465, 2000, pp. 347-354

Modulation of the immune response through 4-1BB

Authors: Sica, G Chen, LP

Citation: G. Sica et Lp. Chen, Modulation of the immune response through 4-1BB, ADV EXP MED, 465, 2000, pp. 355-362

Heat shock proteins in cancer therapy

Authors: Lukacs, KV Pardo, OE Colston, MJ Geddes, DM Alton, EWFW

Citation: Kv. Lukacs et al., Heat shock proteins in cancer therapy, ADV EXP MED, 465, 2000, pp. 363-368

Bi-specific antibodies in cancer therapy

Authors: Wang, H Liu, YJ Wei, LX Guo, YJ

Citation: H. Wang et al., Bi-specific antibodies in cancer therapy, ADV EXP MED, 465, 2000, pp. 369-380

B7.1 and cytokines - Synergy in cancer gene therapy

Authors: Kuiper, M Sanches, R Bignon, YJ Farzaneh, F

Citation: M. Kuiper et al., B7.1 and cytokines - Synergy in cancer gene therapy, ADV EXP MED, 465, 2000, pp. 381-390

Intralesional vaccinia/GM-CSF recombinant virus in the treatment of metastatic melanoma

Authors: Mastrangelo, MJ Maguire, HC Lattime, EC

Citation: Mj. Mastrangelo et al., Intralesional vaccinia/GM-CSF recombinant virus in the treatment of metastatic melanoma, ADV EXP MED, 465, 2000, pp. 391-400

Approaches to gene-directed enzyme prodrug therapy (GDEPT)

Authors: Springer, CJ Niculescu-Duvaz, I

Citation: Cj. Springer et I. Niculescu-duvaz, Approaches to gene-directed enzyme prodrug therapy (GDEPT), ADV EXP MED, 465, 2000, pp. 403-409

Suicide gene therapy

Authors: Freeman, SM

Citation: Sm. Freeman, Suicide gene therapy, ADV EXP MED, 465, 2000, pp. 411-422

Adenoviruses as gene delivery vectors

Authors: Sandmair, AM Vapalahti, M Yla-Herttuala, S

Citation: Am. Sandmair et al., Adenoviruses as gene delivery vectors, ADV EXP MED, 465, 2000, pp. 423-429

Evaluation of an inhibitor of DNA methylation, 5-AZA-2 '-deoxycytidine, for the treatment of lung cancer and the future role of gene therapy

Authors: Momparler, RL Eliopoulos, N Ayoub, J

Citation: Rl. Momparler et al., Evaluation of an inhibitor of DNA methylation, 5-AZA-2 '-deoxycytidine, for the treatment of lung cancer and the future role of gene therapy, ADV EXP MED, 465, 2000, pp. 433-446

Vascular endothelial growth factor as a target for cancer gene therapy

Authors: Nguyen, JT

Citation: Jt. Nguyen, Vascular endothelial growth factor as a target for cancer gene therapy, ADV EXP MED, 465, 2000, pp. 447-456

Adeno-associated virus and other potential vectors for angiostatin and endostatin gene therapy

Authors: Nguyen, JT

Citation: Jt. Nguyen, Adeno-associated virus and other potential vectors for angiostatin and endostatin gene therapy, ADV EXP MED, 465, 2000, pp. 457-466

Potential applications of tissue inhibitor of metalloproteinase (TIMP) overexpression for cancer gene therapy

Authors: Baker, AH Ahonen, M Kahari, VM

Citation: Ah. Baker et al., Potential applications of tissue inhibitor of metalloproteinase (TIMP) overexpression for cancer gene therapy, ADV EXP MED, 465, 2000, pp. 469-483

Risultati: 1-25 | 26-41 |